MENU
+Compare
OASMY
Stock ticker: OTC
AS OF
Nov 5 closing price
Price
$0.01
Change
-$0.00 (-0.00%)
Capitalization
13.08M

OASMY VIVESTO AB Forecast, Technical & Fundamental Analysis

Vivesto AB is a research and development company that develops new treatment options for patients suffering from difficult-to-treat cancer... Show more

OASMY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for OASMY with price predictions
Nov 12, 2025

OASMY in downward trend: price dove below 50-day moving average on October 30, 2025

OASMY moved below its 50-day moving average on October 30, 2025 date and that indicates a change from an upward trend to a downward trend. In of 16 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 30, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on OASMY as a result. In of 37 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for OASMY turned negative on October 30, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 26 similar instances when the indicator turned negative. In of the 26 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 10-day moving average for OASMY crossed bearishly below the 50-day moving average on October 30, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.120) is normal, around the industry mean (18.827). P/E Ratio (0.000) is within average values for comparable stocks, (71.764). OASMY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.856). OASMY has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (0.000) is also within normal values, averaging (39.291).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. OASMY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OASMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
OASMY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published Dividends

OASMY paid dividends on April 04, 2022

VIVESTO AB OASMY Stock Dividends
А quarterly dividend of $0.00 per share was paid with a record date of April 04, 2022, and an ex-dividend date of March 25, 2022. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
Gustav III:s Boulevard 46
Phone
+46 18505440
Employees
18
Web
https://www.vivesto.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MBBC10.950.20
+1.86%
Marathon Bancorp Inc
FINW18.45-0.61
-3.20%
FinWise Bancorp
AMTM22.16-0.80
-3.48%
Amentum Holdings Inc
NEM89.72-3.35
-3.60%
Newmont Corp
ABCL3.62-0.35
-8.82%
AbCellera Biologics

OASMY and Stocks

Correlation & Price change

A.I.dvisor tells us that OASMY and MVMDF have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OASMY and MVMDF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OASMY
1D Price
Change %
OASMY100%
N/A
MVMDF - OASMY
9%
Poorly correlated
-15.12%
MKGAF - OASMY
4%
Poorly correlated
+0.83%
PCLOF - OASMY
2%
Poorly correlated
N/A
OMID - OASMY
2%
Poorly correlated
N/A
OILFF - OASMY
1%
Poorly correlated
-0.92%
More

Groups containing OASMY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OASMY
1D Price
Change %
OASMY100%
N/A
Pharmaceuticals: Generic
industry (214 stocks)
2%
Poorly correlated
-1.00%
Pharmaceuticals
industry (378 stocks)
1%
Poorly correlated
-0.99%